Depression is treatable.

Mode of access: Internet.

Autoconceito e capacidades fisicas de idosos depessivos e não depressivos participantes de um programa de atividade fisica de longa duração

Universidade Estadual de Campinas . Faculdade de Educação Física

La relación angustia depresión desde una perspectiva clínica

Se analizan, desde el punto de vista clinico, las relaciones existentes entre angustia y depresión, según la hipótesis unitaria (ambos estados serían variantes dentro de un mismo núcleo afectivo) o binaria (ambas entidades son totalmente independientes). Se expone, por último, una interpretación personal de este problema.

Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol.

Background: Treatment of depression, the most prevalent and costly mental disorder, needs to be improved. Non-concordance with clinical guidelines and non-adherence can limit the efficacy of pharmacological treatment of depression. Through pharmaceutical care, pharmacists can improve patients' compliance and wellbeing. The aim of this study is to evaluate the effectiveness and costeffectiveness of a community pharmacist intervention developed to improve adherence and outcomes of primary care patients with depression. Methods/design: A randomized controlled trial, with 6-month follow-up, comparing patients receiving a pharmaceutical care support programme in primary care with patients receiving usual care. The total sample comprises 194 patients (aged between 18 and 75) diagnosed with depressive disorder in a primary care health centre in the province of Barcelona (Spain). Subjects will be asked for written informed consent in order to participate in the study. Diagnosis will be confirmed using the SCID-I. The intervention consists of an educational programme focused on improving knowledge about medication, making patients aware of the importance of compliance, reducing stigma, reassuring patients about side-effects and stressing the importance of carrying out general practitioners' advice. Measurements will take place at baseline, and after 3 and 6 months. Main outcome measure is compliance with antidepressants. Secondary outcomes include; clinical severity of depression (PHQ-9), anxiety (STAI-S), health-related quality of life (EuroQol-5D), satisfaction with the treatment received, side-effects, chronic physical conditions and sociodemographics. The use of healthcare and social care services will be assessed with an adapted version of the Client Service Receipt Inventory (CSRI). Discussion: This trial will provide valuable information for health professionals and policy makers on the effectiveness and cost-effectiveness of a pharmaceutical intervention programme in the context of primary care. Trial registration: NCT00794196

Correlación entre diversos cuestionarios de ansiedad y depresión

En nuestra práctica clínica observamos la insuficiencia de los cuestionarios como método diagnostico, especialmente cuando se trata de establecer diferencias cualitativas entre cuadros de angustia y depresión. Esta hipótesis se ha confirmado al realizar correlaciones entre 6 cuestionarios (tres de angustia y tres de depresión), que se administraron a 41 pacientes (28 angustiados y 13 depresivos) y observar el elevado indice de interrelaciones existentes entre ellos. Los pacientes depresivos tienden a puntuar alto, tanto en los cuestionarios de depresión como en los de angustia, mientras que los angustiados solo lo hacen en estos últimos.

Ansiedad y depresión en parejas que incian un tratamiento de fecundación in vitro (FIV): rol de las estrategias de afrontamiento

Living with infertility and its emotional impact in couples has been frequently investigated. The objective of the present study was to establish in couples that initiate an IVF treatment:(1) their coping profile, anxiety level (State-anxiety; Trait-anxiety) and depression symptomatology;(2) the explanatory power of coping strategies over anxiety and depression levels, depending on gender. Method: we used a transversal study with 92 couples that begun an IVF treatment in the Assisted Reproduction Unit of the Hospital Clinic. All of them respond to the Spanish adaptation of the CRI-A, the STAI and the BDI-I. Results: the IVF population in comparison to the normal sample use less coping strategies and presents lower levels of anxiety and depression. Women IVF in comparison with man employ further avoidance strategies and present a higher score in depression and state-anxiety. Even when some exceptions exist, anxiety and depression levels are not well explained by coping strategies. Conclusions: It has been shown that the use of coping strategies on the IVF population are lower than in normative sample. Most of the couples present low anxiety (state / trait) and depression levels, and just a low percentage present scores that can require clinical attention. Key words: Infertility / IVF / Coping strategies / State anxiety / Trait anxiety / depression.

Análisis de contenido de constructos personales en la depresión

Desde el marco de la Psicología de los Constructos Personales (PCP) de Kelly, es posible estudiar de forma sistemática la construcción subjetiva que las personas hacen de sí mismas y de sus problemas. Feixas et al. destacan la pertinencia del estudio de los sistemas de construcción en la evaluación del trastorno depresivo puesto que miden aspectos que no son suficientemente valorados por las medidas cognitivas estándar sobre los síntomas y las distorsiones cognitivas. La mayoría de los trabajos sobre la depresión basados en la PCP se han centrado en las características estructurales, en cambio los aspectos del contenido han recibido menor interés. El propósito de este estudio es realizar un análisis de contenido de los constructos personales en la depresión. Actualmente no existe ningún estudio que haya explorado de forma sistemática las dimensiones de contenido más significativas para esta población. En concordancia con la PCP y otros enfoques cognitivos, hipotetizamos que el contenido de los sistemas de construcción de la muestra depresiva es distinto al de la población normal. En concreto, creemos que la población clínica presenta mayor frecuencia de constructos de tipo moral y emocional en comparación con la muestra no clínica. Para poder poner a prueba estas hipótesis se analizaron los constructos de 106 sujetos, con edades comprendidas entre los 19 y los 57 años, divididos en dos grupos, un grupo clínico (n=53) de personas diagnosticadas con alguna modalidad depresiva unipolar y otro grupo no clínico (n=53). Categorizamos el contenido de los constructos elicitados con la técnica de rejilla por medio del Sistema de Categorías de Constructos Personales (SCCP) desarrollado por Feixas et al. El SCCP es un sistema de clasificación compuesto por un total de seis áreas temáticas (moral, emocional, relacional, personal, intelectual y valores e intereses) que se desglosan en 45 categorías para codificar el contenido de los constructos personales. Los principales resultados muestran que existen diferencias significativas entre las distribuciones de frecuencias del contenido de ambas poblaciones. Las personas con depresión (PD) utilizan significativamente más constructos de tipo emocional, y menos de tipo intelectual. Además, en comparación a la muestra normal, los depresivos muestran mayor número de constructos en las categorías «reflexiva-superficial», «tolerante-autoritaria» y, de forma más destacada, en la dimensión «fuerte-débil». Los resultados indican que el patrón prototípico del contenido de los sistemas de constructos de las PD difiere en el énfasis temático predominante. En efecto, de la variedad de acontecimientos de la experiencia, los aspectos conativos resultan especialmente notorios para las personas con depresión. Por otro lado, la carencia de constructos intelectuales y personales refuerza la idea de que las personas con depresión emplean gran parte de su actividad mental en el procesamiento de los aspectos emocionales de la experiencia. Aunque la naturaleza exploratoria de este estudio no permite establecer líneas causales, parece evidente que la focalización de la actividad psicológica de las PD en la dimensión afectiva de la experiencia puede estar desempeñando un papel importante en el mantenimiento de la problemática depresiva. Por último, a partir de las limitaciones de este estudio se proponen algunos diseños para la investigación futura acerca de la relación entre el contenido y la estructura de los sistemas de construcción de las personas con depresión.

Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol.

Background: Treatment of depression, the most prevalent and costly mental disorder, needs to be improved. Non-concordance with clinical guidelines and non-adherence can limit the efficacy of pharmacological treatment of depression. Through pharmaceutical care, pharmacists can improve patients' compliance and wellbeing. The aim of this study is to evaluate the effectiveness and costeffectiveness of a community pharmacist intervention developed to improve adherence and outcomes of primary care patients with depression. Methods/design: A randomized controlled trial, with 6-month follow-up, comparing patients receiving a pharmaceutical care support programme in primary care with patients receiving usual care. The total sample comprises 194 patients (aged between 18 and 75) diagnosed with depressive disorder in a primary care health centre in the province of Barcelona (Spain). Subjects will be asked for written informed consent in order to participate in the study. Diagnosis will be confirmed using the SCID-I. The intervention consists of an educational programme focused on improving knowledge about medication, making patients aware of the importance of compliance, reducing stigma, reassuring patients about side-effects and stressing the importance of carrying out general practitioners' advice. Measurements will take place at baseline, and after 3 and 6 months. Main outcome measure is compliance with antidepressants. Secondary outcomes include; clinical severity of depression (PHQ-9), anxiety (STAI-S), health-related quality of life (EuroQol-5D), satisfaction with the treatment received, side-effects, chronic physical conditions and sociodemographics. The use of healthcare and social care services will be assessed with an adapted version of the Client Service Receipt Inventory (CSRI). Discussion: This trial will provide valuable information for health professionals and policy makers on the effectiveness and cost-effectiveness of a pharmaceutical intervention programme in the context of primary care. Trial registration: NCT00794196

The psychosocial difficulties in brain disorders that explain short term changes in health outcomes.

BACKGROUND: This study identifies a set of psychosocial difficulties that are associated with short term changes in health outcomes across a heterogeneous set of brain disorders, neurological and psychiatric. METHODS: Longitudinal observational study over approximately 12 weeks with three time points of assessment and 741 patients with depression, bipolar disorders, multiple sclerosis, parkinson's disease, migraine, traumatic brain injury and stroke. The data on disability was collected with the checklist of the International Classification of Functioning, Disability and Health. The selected health outcomes were the Short Form 36 and the World Health Organization Disability Assessment Schedule. Multilevel models for change were applied controlling for age, gender and disease severity. RESULTS: The psychosocial difficulties that explain the variability and change over time of the selected health outcomes were energy and drive, sleep, and emotional functions, and a broad range of activities and participation domains, such as solving problems, conversation, areas of mobility and self-care, relationships, community life and recreation and leisure. CONCLUSIONS: Our findings are of interest to researchers and clinicians for interventions and health systems planning as they show that in addition to difficulties that are diagnostic criteria of these disorders, there are other difficulties that explain small changes in health outcomes over short periods of time.

Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd Study)

BACKGROUND: Studies in bipolar disorder (BD) to date are limited in their ability to provide a whole-disease perspective--their scope has generally been confined to a single disease phase and/or a specific treatment. Moreover, most clinical trials have focused on the manic phase of disease, and not on depression, which is associated with the greatest disease burden. There are few longitudinal studies covering both types of patients with BD (I and II) and the whole course of the disease, regardless of patients' symptomatology. Therefore, the Wide AmbispectiVE study of the clinical management and burden of Bipolar Disorder (WAVE-bd) (NCT01062607) aims to provide reliable information on the management of patients with BD in daily clinical practice. It also seeks to determine factors influencing clinical outcomes and resource use in relation to the management of BD. METHODS: WAVE-bd is a multinational, multicentre, non-interventional, longitudinal study. Approximately 3000 patients diagnosed with BD type I or II with at least one mood event in the preceding 12 months were recruited at centres in Austria, Belgium, Brazil, France, Germany, Portugal, Romania, Turkey, Ukraine and Venezuela. Site selection methodology aimed to provide a balanced cross-section of patients cared for by different types of providers of medical aid (e.g. academic hospitals, private practices) in each country. Target recruitment percentages were derived either from scientific publications or from expert panels in each participating country. The minimum follow-up period will be 12 months, with a maximum of 27 months, taking into account the retrospective and the prospective parts of the study. Data on demographics, diagnosis, medical history, clinical management, clinical and functional outcomes (CGI-BP and FAST scales), adherence to treatment (DAI-10 scale and Medication Possession Ratio), quality of life (EQ-5D scale), healthcare resources, and caregiver burden (BAS scale) will be collected. Descriptive analysis with common statistics will be performed. DISCUSSION: This study will provide detailed descriptions of the management of BD in different countries, particularly in terms of clinical outcomes and resources used. Thus, it should provide psychiatrists with reliable and up-to-date information about those factors associated with different management patterns of BD. TRIAL REGISTRATION NO: ClinicalTrials.gov: NCT01062607.

Implicación de la ansiedad y la depresión en los trastronos de alimentación de jovenes con obesidad

Objectives: the goals of the present study were: 1) to compare the levels of anxiety, depression, and eating disorders in young patients assisted at a children"s hospital for obesity; 2) to determine whether anxiety and depression explain the symptoms of the eating disorders; and 3) to know which of these symptoms better discriminate the young people with different degrees of obesity. Materials and method: Descriptive, cross-sectional study with a sample comprised by 281 youngsters (56% girls) aged 11-17 years. The BMI percentiles were calculated by using the WHO growth tables. Two study groups were created: severe obesity and overweight/light-moderate obesity. The following questionnaires were used: Eating Disorders Inventory-2 (EDI-2), depression questionnaire (DQ), and Status-Trait Anxiety Questionnaire (STAI). Results: The youngsters with obesity showed more psychological problems than youngsters with overweight/ light-moderate obesity, 12% had anxiety, and 11% depression. In both groups, the behaviours related with eating disorders were partially explained by the presence of symptoms of anxiety and depression. Dissatisfaction with the body and high anxiety trait increased the risk for perpetuating the obesity and were the two symptoms that better discriminated the patients with or without severe obesity. Conclusion: Obesity prevention programmes should include body dissatisfaction and the anxiety trait into the assessment and management protocols, and prevent anxiety getting fixed as a personality trait.

Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis

BACKGROUND: Pharmacists can play a decisive role in the management of ambulatory patients with depression who have poor adherence to antidepressant drugs. OBJECTIVE: To systematically evaluate the effectiveness of pharmacist care in improving adherence of depressed outpatients to antidepressants. METHODS: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted. RCTs were identified through electronic databases (MEDLINE, Cochrane Central Register of Controlled Trials, Institute for Scientific Information Web of Knowledge, and Spanish National Research Council) from inception to April 2010, reference lists were checked, and experts were consulted. RCTs that evaluated the impact of pharmacist interventions on improving adherence to antidepressants in depressed patients in an outpatient setting (community pharmacy or pharmacy service) were included. Methodologic quality was assessed and methodologic details and outcomes were extracted in duplicate. RESULTS: Six RCTs were identified. A total of 887 patients with an established diagnosis of depression who were initiating or maintaining pharmacologic treatment with antidepressant drugs and who received pharmacist care (459 patients) or usual care (428 patients) were included in the review. The most commonly reported interventions were patient education and monitoring, monitoring and management of toxicity and adverse effects, adherence promotion, provision of written or visual information, and recommendation or implementation of changes or adjustments in medication. Overall, no statistical heterogeneity or publication bias was detected. The pooled odds ratio, using a random effects model, was 1.64 (95% CI 1.24 to 2.17). Subgroup analysis showed no statistically significant differences in results by type of pharmacist involved, adherence measure, diagnostic tool, or analysis strategy. CONCLUSIONS: These results suggest that pharmacist intervention is effective in the improvement of patient adherence to antidepressants. However, data are still limited and we would recommend more research in this area, specifically outside of the US.

Terapia sistémica de pareja en la depresión: un estudio de caso único

En este estudio de caso único se presenta el tratamiento de una mujer diagnosticada de depresión mayor con terapia sistémica de pareja. Esta modalidad de terapia supone la inclusión de la pareja en todas las sesiones de tratamiento, en las que se trabaja con ambos de forma conjunta. A medida que avanza la terapia se van explicitando los significados relacionales de los síntomas y las dificultades de relación, y se trabaja de forma conjunta para remediarlas. El proceso terapéutico se completó con 11 sesiones, la mayoría quincenales, y los resultados de la evaluación al terminar el tratamiento mostraron un descenso notable de los síntomas depresivos de la paciente (según el BDI-II) con respecto a la evaluación inicial. Asimismo, en la entrevista diagnóstica post-tratamiento no cumplía tampoco los criterios de depresión mayor. En cuanto a la pareja, ambos percibieron la relación como más armónica (según el DAS). Dentro de las limitaciones propias de los estudios de caso único, este trabajo permite ilustrar las potencialidades del enfoque sistémico en el tratamiento de la depresión.

Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd Study)

BACKGROUND: Studies in bipolar disorder (BD) to date are limited in their ability to provide a whole-disease perspective--their scope has generally been confined to a single disease phase and/or a specific treatment. Moreover, most clinical trials have focused on the manic phase of disease, and not on depression, which is associated with the greatest disease burden. There are few longitudinal studies covering both types of patients with BD (I and II) and the whole course of the disease, regardless of patients' symptomatology. Therefore, the Wide AmbispectiVE study of the clinical management and burden of Bipolar Disorder (WAVE-bd) (NCT01062607) aims to provide reliable information on the management of patients with BD in daily clinical practice. It also seeks to determine factors influencing clinical outcomes and resource use in relation to the management of BD. METHODS: WAVE-bd is a multinational, multicentre, non-interventional, longitudinal study. Approximately 3000 patients diagnosed with BD type I or II with at least one mood event in the preceding 12 months were recruited at centres in Austria, Belgium, Brazil, France, Germany, Portugal, Romania, Turkey, Ukraine and Venezuela. Site selection methodology aimed to provide a balanced cross-section of patients cared for by different types of providers of medical aid (e.g. academic hospitals, private practices) in each country. Target recruitment percentages were derived either from scientific publications or from expert panels in each participating country. The minimum follow-up period will be 12 months, with a maximum of 27 months, taking into account the retrospective and the prospective parts of the study. Data on demographics, diagnosis, medical history, clinical management, clinical and functional outcomes (CGI-BP and FAST scales), adherence to treatment (DAI-10 scale and Medication Possession Ratio), quality of life (EQ-5D scale), healthcare resources, and caregiver burden (BAS scale) will be collected. Descriptive analysis with common statistics will be performed. DISCUSSION: This study will provide detailed descriptions of the management of BD in different countries, particularly in terms of clinical outcomes and resources used. Thus, it should provide psychiatrists with reliable and up-to-date information about those factors associated with different management patterns of BD. TRIAL REGISTRATION NO: ClinicalTrials.gov: NCT01062607.

Teoría de la personalidad implícita y explícita de los pacientes con depresión

Resumen: En el presente trabajo se comparan las teorías implícitas con la teoría explícita de la personalidad depresiva. Se administró un listado de ad-jetivos para la heteroevaluación de la depresión a un total de 400 participan-tes, distribuidos en cuatro grupos: a) depresivos, b) población general, c) médicos y d) diplomados en enfermería. A los pacientes depresivos se les volvió a administrar el listado de adjetivos para su autoevaluación. Se llevó a cabo un estudio descriptivo mediante la prueba de χ2 para discriminar los adjetivos utilizados entre los grupos. Seguidamente se realizaron ANOVAs para establecer diferencias por grupos a partir de la heteroevaluación y para comprobar si había diferencias entre la heteroevaluación y la autoevaluación de las personas depresivas. El análisis de los resultados constata la existen-cia de diferencias en el estereotipo de las personas depresivas por parte del grupo clínico depresivo, del grupo médico y del grupo de enfermería pero no indicios de estigmatización. Sin embargo, en el grupo general distingui-mos una creencia prejuiciosa en su percepción de las personas depresivas. Las personas con trastorno depresivo manifiestan una heteroevaluación de la depresión más positiva que su propia autoevaluación.